| abstract |
CHARACTERIZED BECAUSE IT INCLUDES a) AN INSULIN SENSITIZER AS 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] -BENCIL] THIAZOLIDINE-2,4-DIONA OR TROGLITAZONE, OR CIGLITAZONE, PIOGLITAZONE OR ENGLITAZONA; b) AN INSULIN SECRETAGOGUE MAY BE A SULFONILUREA SUCH AS GLIBENCLAMIDA, GLIPIZIDA, GLICLAZIDA, GLIMEPIRIDA, TOLAZAMIDA, TOLBUTAMIDA, CARBUTAMINE, AUSTRIA, BORUTHORIN, AUSTRIA THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND THE CONDITIONS ASSOCIATED WITH DIABETES MELLITUS |